Division of Gastroenterology and Hepatology

Medicine & Life Sciences

1. Helicobacter pylori 100%
2. Colorectal Neoplasms 93%
3. Hepatocellular Carcinoma 82%
4. Taiwan 82%
5. Neoplasms 64%
6. Chronic Hepatitis B 63%
7. Stomach 63%
8. Stomach Neoplasms 51%
9. Chronic Hepatitis C 49%
10. Therapeutics 43%
11. Apoptosis 42%
12. Liver Cirrhosis 36%
13. Carcinoma 34%
14. Liver 31%
15. Proteins 30%
16. Non-alcoholic Fatty Liver Disease 30%
17. Colonic Neoplasms 29%
18. Helicobacter Infections 28%
19. Colonoscopy 27%
20. Fibrosis 27%
21. Duodenal Ulcer 27%
22. Adenocarcinoma 26%
23. cytolethal distending toxin 26%
24. Interferons 25%
25. 15,16-dihydrotanshinone I 25%
26. Endoscopic Mucosal Resection 24%
27. Serum 24%
28. Intussusception 24%
29. Ulcer 24%
30. Confidence Intervals 23%
31. Hepacivirus 23%
32. Hepatitis B virus 21%
33. Neoplastic Stem Cells 21%
34. velpatasvir 21%
35. Population 20%
36. Raman Spectrum Analysis 20%
37. Odds Ratio 20%
38. Fatty Liver 20%
39. Neoplasm Metastasis 20%
40. evodiamine 20%
41. Chromosome Segregation 20%
42. Catenins 20%
43. Cetuximab 19%
44. Drug Therapy 19%
45. Hydroxymethylglutaryl-CoA Reductase Inhibitors 19%
46. Recurrence 19%
47. Cohort Studies 19%
48. Alanine Transaminase 19%
49. Pylorus 18%
50. Metaplasia 18%
51. Cellular Apoptosis Susceptibility Protein 18%
52. Sofosbuvir 18%
53. Survival 18%
54. Hepatitis 18%
55. Hepatitis B 18%
56. Peptic Ulcer 18%
57. Pancreatic Neoplasms 18%
58. ErbB Receptors 17%
59. Meta-Analysis 17%
60. Systematic Reviews 17%
61. Mucous Membrane 17%
62. Lipopolysaccharides 17%
63. glucose-regulated proteins 17%
64. lipoteichoic acid 17%
65. Inflammation 16%
66. Gastrointestinal Diseases 16%
67. Heme Oxygenase-1 16%
68. Evodia 16%
69. Campylobacter jejuni 16%
70. Cholesterol 15%
71. Biomarkers 15%
72. Growth 15%
73. Reactive Oxygen Species 15%
74. Liver Diseases 15%
75. Sorafenib 15%
76. Epithelial Cells 15%
77. Fluorouracil 15%
78. Cell Proliferation 15%
79. Digestive System Endoscopy 14%
80. Antiviral Agents 14%
81. Phosphotransferases 14%
82. Nitric Oxide 14%
83. Mutation 14%
84. Radiofrequency Ablation 14%
85. Prostatic Neoplasms 14%
86. Safety 14%
87. Esomeprazole 14%
88. Solanum nigrum 14%
89. Esophagitis 14%
90. Endoscopy 13%
91. Renal Dialysis 13%
92. Cisplatin 13%
93. Cell Line 13%
94. Gastritis 13%
95. Stomach Ulcer 13%
96. osthol 13%
97. Genotype 12%
98. Pancreatitis 12%
99. Randomized Controlled Trials 12%